Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Emerging evidence suggests the potential benefits of GLP-1 RAs in the treatment of IBD through enhanced mucosal healing and reduced inflammation
Musazadeh et al
According to the Rome IV criteria, such disorders can involve any combination of motility disturbance, altered mucosal and immune function, dysbiosis of gut microbiota, visceral hypersensitivity, and altered central nervous system processing (5)
Highly accurate protein structure prediction with AlphaFold
US$ 22.27
US$ 26.18
US$ 21.20
